FDA.reportPublic FDA data

Nevanac 1 MG/ML Ophthalmic Suspension

RxCUI
603978
RxNorm name
Nevanac 1 MG/ML Ophthalmic Suspension
Display name
Nevanac 1 MG/ML Ophthalmic Suspension
Full name
Nevanac 1 MG/ML Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NEVANACNEPAFENACHarrow Eye, LLC11b9a0cf-2a70-17ef-e063-6394a90a5d9e2024-11-05Warnings, Adverse reactionsExact identifier
rxcui: 603978

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
11b9a0cf-2a70-17ef-e063-6394a90a5d9eNevanac 1 MG/ML Ophthalmic SuspensionSY3These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520241105
11b9a0cf-2a70-17ef-e063-6394a90a5d9eNevanac 0.1 % Ophthalmic SuspensionSY3These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520241105
11b9a0cf-2a70-17ef-e063-6394a90a5d9eNevanac 0.1 % Ophthalmic SuspensionPSN3These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520241105
11b9a0cf-2a70-17ef-e063-6394a90a5d9enepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]SBD3These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520241105
a2909252-c5f1-421f-9073-b7be90b45b51nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]SBD2These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520230419
a2909252-c5f1-421f-9073-b7be90b45b51Nevanac 0.1 % Ophthalmic SuspensionSY2These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520230419
a2909252-c5f1-421f-9073-b7be90b45b51Nevanac 0.1 % Ophthalmic SuspensionPSN2These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520230419
a2909252-c5f1-421f-9073-b7be90b45b51Nevanac 1 MG/ML Ophthalmic SuspensionSY2These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 200520230419
52fe0332-388a-451c-b759-97e760883837Nevanac 0.1 % Ophthalmic SuspensionSY1These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 200520110831
52fe0332-388a-451c-b759-97e760883837Nevanac 0.1 % Ophthalmic SuspensionPSN1These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 200520110831
52fe0332-388a-451c-b759-97e760883837Nevanac 1 MG/ML Ophthalmic SuspensionSY1These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 200520110831
52fe0332-388a-451c-b759-97e760883837nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]SBD1These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 200520110831